| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |